Skip to main content
OpenTrials

Clinical trial condition

Epstein-Barr Virus Infections

Explore clinical trials studying Epstein-Barr Virus Infections. Study availability and eligibility vary by location and protocol.

125 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Epstein-Barr Virus Infections trial results

Recruiting

Donor-Derived Viral Specific T-cells (VSTs)

NCT02048332

Conditions
Adenoviridae Infections, Allogeneic Stem Cell Transplant, DNA Virus Infections, +7 more
Locations
  • Akron Children's Hospital Akron, Ohio, United States
  • University of Cincinnati Medical Center Cincinnati, Ohio, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Recruiting

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

NCT03266653

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Epstein-Barr Virus Infections, +9 more
Locations
  • Children's Hosptial Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Recruiting

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

NCT05592626

Conditions
Abdominal Neoplasm, Abdominal Neoplasms, Adenocarcinoma, +89 more
Locations
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • AdventHealth Celebration Celebration, Florida, United States
View all 32 locations
View Trial Details
Recruiting

Multi-Center Registry for ME/CFS

NCT05778006

Conditions
CFS/ME, Chronic Disease, DNA Virus Infections, +18 more
Locations
  • MRI Chronic Fatigue Center for Young People (MCFC) Children's Hospital, Technical University of Munich & Munich Municipal Hospital Munich, Bavaria, Germany
View Trial Details
Recruiting

Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft

NCT04989491

Conditions
DNA Virus Infections, Epstein-Barr Virus Infections, Herpesviridae Infections, +3 more
Locations
  • Les Hôpitaux Universitaires de Strasbourg Strasbourg, France
View Trial Details

Related conditions